GL Pharm Tech

GL Pharm Tech Corp. is a South Korean pharmaceutical company headquartered in Seongnam, Gyeonggi-do, focused on developing improved formulations of existing marketed drugs with reduced side effects. The company's pipeline includes extended-release, enteric-coated, and topical formulations across areas such as neurology, gastroenterology, and oncology, and it holds drug patents registered in South Korea, China, and Japan. GL Pharm Tech develops generic and new-drug-classification products and markets approved medicines including Cavalin CR (pregabalin extended-release tablets) and other prescription drugs, serving the domestic pharmaceutical market with ambitions for global expansion.